Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

autologous IL-7-expressing TILs ADP-TILIL7

A preparation of autologous tumor infiltrating lymphocytes (TILs) engineered to express the cytokine interleukin-7 (IL-7), with potential immunomodulating and antineoplastic activities. The TILs are isolated from an autologous tumor sample and transduced with a lentiviral vector to express IL-7. Upon infusion of the autologous IL-7-expressing TILs ADP-TILIL7 back into the patient, the TILs specifically recognize, target and kill the patient's tumor cells. IL-7 is a cytokine that promotes the proliferation and survival of T cells and may enhance the activity and durability of the TILs.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:autologous engineered TILs ADP-TILIL7
autologous IL-7-transduced TILs ADP-TILIL7
autologous TILs expressing IL-7 ADP-TILIL7
Code name:ADP TILIL7
ADP-TILIL7
ADPTILIL7
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search